Navigation Links
Astellas Hires New Vice President of Compliance
Date:6/2/2009

DEERFIELD, Ill., June 2 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas") recently hired Dan Dunham as the vice president of compliance. Dunham will be responsible for governance of the compliance program to ensure Astellas' observance of federal and state health care program requirements and regulations.

"We are very pleased to add Dan to our senior management team to provide strategic direction and leadership for the compliance department," said Seigo Kashii, president and CEO of Astellas. "He brings with him 30 years of legal, compliance and extensive pharmaceutical experience, which will accelerate Astellas toward our company goals."

Prior to joining Astellas, Dunham held legal positions at Pfizer Inc., Pharmacia Corporation and Warner-Lambert Company. He managed civil and criminal investigations into manufacturing, laboratory, marketing and promotion and pricing practices, and supervised a docket of domestic and international commercial and products liability lawsuits. While at Warner-Lambert, Dunham created and implemented that company's worldwide corporate compliance program and office. Dunham earned his law degree from Columbia University School of Law and his undergraduate degree at the University of South Dakota.

About Astellas

Astellas Pharma US, Inc., located in Deerfield, Illinois, is a U.S. affiliate of Tokyo-based Astellas Pharma Inc. Astellas is a pharmaceutical company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products. The organization is committed to becoming a global category leader in focused areas by combining outstanding R&D and marketing capabilities. In the US, Astellas markets products in the areas of Immunology, Urology, Anti-Infectives, Cardiovascular and Dermatology. For more information about Astellas Pharma US, Inc., please visit our website at www.us.astellas.com.


'/>"/>
SOURCE Astellas Pharma US, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cardiome And Astellas Announce Regulatory Update
2. FDA Approves Additional Indication for Astellas MYCAMINE(R)
3. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
4. Astellas Launches Vaprisol(R) (Conivaptan Hydrochloride Injection) Premixed in 5% Dextrose for the Treatment of Hyponatremia
5. Astellas Announces New Vice President of Marketing
6. Pioneer Surgical Technology Hires Vice President of New Business Development
7. WeissComm Partners Makes 10 New Hires as It Wins New Accounts and Grows Existing Business
8. LehmanMillet Continues Expansion with Strategic Hires
9. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business
10. Staffing Agency Hires Local Television News Team, Launches Broadband Network for Nurses
11. Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally recognized ... have expanded their existing home health joint venture through an agreement, effective October ... a joint venture home health company with Asante, delivering clinically integrated care, for ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... Hair Restoration, has recently contributed a medical article to the newly revamped ... Dr. Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... Leading pediatric ... peers in Washington, D.C., for the 49th Congress of the International Society of ... Vice President of the Center for Cancer and Blood Disorders at Children’s ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... one of Michigan’s 2017 Best and Brightest in Wellness® by Best and Brightest. ... awards program on Friday, Oct. 20 from 7:30 a.m. to 2 p.m. at ...
(Date:10/12/2017)... ... 2017 , ... In the United States, single-family home owners ... New York, New Jersey, Massachusetts, Texas, Virginia, Connecticut, and California—the average is $7,000 ... property-tax rates, which contributes to the relatively lower cost of living in places ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... Sept. 25, 2017  EpiVax, Inc., a leader ... and immune-engineering today announced the launch of EpiVax ... of personalized therapeutic cancer vaccines. EpiVax has provided ... access to enabling technologies to the new precision ... lead EpiVax Oncology as Chief Executive Officer. Gad ...
(Date:9/22/2017)... 22, 2017  As the latest Obamacare repeal effort ... Cassidy (R-LA) and Lindsey Graham (R-SC) ... medical device industry is in an odd place.  The ... 2.3% excise tax on medical device sales passed along ... covered patients, increased visits and hospital customers with the ...
Breaking Medicine Technology: